期刊文献+

VEGF、MMP-9、TIMP-2在口腔颌面部鳞癌中的表达研究 被引量:7

Expression and significance of VEGF,MMP-9 and TIMP-2 in OSCC
下载PDF
导出
摘要 目的:研究口腔鳞癌中VEGF、MMP-9和TIMP-2基因的表达与临床病理因素之间的关系及意义。方法:应用免疫组织化学Envision法检测VEGF、MMP-9和TIMP-2在50例口腔鳞癌中的表达,分析其与口腔鳞癌的临床及病理参数之间的关系。结果:VEGF在口腔鳞癌中阳性表达率与其有无淋巴结转移相关,有淋巴结转移者VEGF的表达量较无淋巴结转移者明显增加(P<0.05)。MMP-9的表达率与其临床分期及有无淋巴结转移相关;临床分期越高,MMP-9的表达越高(P<0.05);有淋巴结转移者MMP-9的表达量较无淋巴结转移者明显增加(P<0.05)。TIMP-2的阳性表达率与T分类、临床分期和有、无淋巴结转移转移有关。随着T分类、临床分期的增高,TIMP-2的表达率明显降低(P<0.05);有淋巴结转移者TIMP-2的表达较无淋巴结转移者明显降低(P<0.05)。结论:VEGF、MMP-9的高表达和TIMP-2的低表达与口腔鳞癌淋巴结转移明显相关。MMP-9的高表达和TIMP-2的低表达与口腔鳞癌的临床分期和疾病进展有一定关系。 Objective: To study the relationship between the expressions of VEGF, MMP-9 and TIMP-2 and clinic-pathologic factors as well as the clinical significance. Methods: The expression of VEGF, MMP-9 and TIMP- 2 in 50 cases of oral squamous cell carcinoma were detected by Envision immunohistochemical technique and the relationship between the expression and the clinical factors of oral squamous cell carcinoma was analyzed. Re- sults: The expression rate of VEGF in oral squamous cell carcinoma was correlated with the lymph node metastasis (P^0.05). The expression rate was higher in the positive lymph node metastasis group than that of the negative lymph node metastasis (P〈0.05). The expression rate of MMP--9 in oral squamous cell carcinoma was correlated with the clinical stage and lymph node metastasis (P 〈0.05). The expression rate was higher in the higher clinical stage (P〈0. 05) and in the positive lymph node metastasis group than that of the higher clinical stage and the nega- tive lymph node metastasis group (P^0.05). The expression rate of TIMP--2 in oral squamous cell ~arcinoma was correlated with the T--category of tumor, the clinical stage and lymph node metastasis (P^0.05). With the higher of the clinical stage, the expression rate became lower. The expression rate was lower in the higher T-- category and the positive lymph node metastasis group than that of the lower T--category and the negative lymph node me- tastasis group (P^0.05). Conclusion: The results indicated that the positive rate of VEGF, MMP--9 and TIMP-- 2 protein in oral squamous cell carcinoma were significantly associated with lymph node metastasis. The results in- cluced that the positive rate of MMP--9 and TIMP--2 protein were significantly correlated with tumor processes in OSCC.
出处 《口腔医学研究》 CAS CSCD 2012年第11期1141-1144,1148,共5页 Journal of Oral Science Research
关键词 VEGF MMP-9 TIMP-2 口腔鳞癌 免疫组化 VEGF MMP 9 TIMP-2 Oral squamous cell carcinoma Immunohistochemistry
  • 相关文献

参考文献11

  • 1温玉明等.《口腔颌面部肿瘤学》[M].北京:人民卫生出版社,2003.
  • 2Yamamoto E. Clinical and experimental studies of mode of invasion in oral cancer [J]. Oral Oncol, 1995, 4(1) : 33-36.
  • 3Ishikawa M, Kitayama J, Kazama S, et al. Expression of vascular endothelial growth factor (VEGF) -C in preopera-tive biopsy speciments and metastatic loci of regional lymph nodes in submucosal gastric carcinoma[J]. World J Surg On- col, 2005, 3(1) : 2.
  • 4陈江,温玉明,李龙江,王昌美.口腔癌血管内皮细胞生长因子(VEGF)表达的初步观察[J].华西口腔医学杂志,2001,19(5):303-305. 被引量:10
  • 5Kaio E, Tanaka S, Kitadai Y, et al. Clinical significance of angiogenic factor expression at the deepest factor expressionat the deepest invasive site of advanced colorectal carcinoma[J]. Oncology, 2003, 64 : 61-73.
  • 6Stacker SA, Hughes RA, Achen MG. Molecular targeting of lymphatics for therapy [J]. Curr Pharm Des, 2004, 10(1) : 65-74.
  • 7陈坤,习利军,姜倩,张铁柱,于立明,凌瑞,谢镇春.CD44V6、MMP-9在舌癌中的表达及其意义[J].口腔医学研究,2010,26(5):740-743. 被引量:8
  • 8Katori H, Baba Y, Imagawa Y, et al. Reduction matrix metal- loproteinase in squamous cell carcinoma cell lines of head and neck[J].Cancer Lett,2002,178(2) : 151-159.
  • 9戴泰鸣,宋宇峰,马洪,冯红超,魏宏琳.口腔鳞癌中MMP-9的表达与巨噬细胞测定的意义[J].中国肿瘤临床,2007,34(16):901-904. 被引量:4
  • 10Franchi A, Santucci M, Masini E, et al. Expression of ma- trix metal opro teinase - 1, matrix metal- oproteinase- 2, and matrix metalloproteinase-9 in carcinoma of the head and neck[J]. Cancer, 2002, 95(9) : 1902-1910.

二级参考文献30

  • 1杨建斌,冯红超,宋宇峰.口腔鳞癌中单核细胞趋化蛋白-1在巨噬细胞浸润、聚集中的意义[J].中国肿瘤临床,2005,32(20):1155-1157. 被引量:10
  • 2[1]Guidi AJ, Abu-Jawdeh G, Berse B, et al. Vascular permeability factor (vascular endothelial growth factor) expression in cervical neoplasia. J Natl Cancer inst, 1995,87(3):1237~1241
  • 3[2]Devorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor. Microvascular hyperpermeability and angiogenesis. Am J Pathol, 1995,146(3):1029~1032
  • 4[3]Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 1995(a),104(2):744~752
  • 5[4]Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.Hum Pathol, 1995(b),26(1):86~90
  • 6[5]Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int, 1992(a),42(5):1457~1465
  • 7[6]Samoto K, Ikezaki K, Mayumi O, et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res, 1995,55(40):1189~1197
  • 8Wong YF, Cheung TH, Tsao GS. Genome--wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray [J]. Int J Cancer, 2006, 118(10) : 2461-2469.
  • 9Cha HJ, Bae SK, Lee, HY, et al. Anti--invasive aetivity of ursolic acid correlates with the reduced expressor of matrix metal proteinaseg (MMP--9) in HT-1080 human fibrosarcoma cells [J]. Cancer Res, 1996, 56(10) : 2281-2284.
  • 10Nguyen VN, Mireiovsky T, Melinova L, et al. CD44 and its v6 spiliced variant in lung carcinoma relation toNCAM, CEA,EMA and UP1 and prognostic significance [J].Neoplasma, 2004, 47(6): 400--408.

共引文献19

同被引文献61

  • 1柳海,李秀,吴强.MMP-2、TIMP-2在口腔鳞状细胞癌中表达的临床病理研究[J].中国肿瘤,2006,15(4):251-254. 被引量:3
  • 2钟崇,郭荣平,石明,韦玮,俞武生,李锦清.VEGF与MMP-9在肝癌组织中的表达及其临床意义[J].癌症,2006,25(5):599-603. 被引量:35
  • 3徐义荣,白莉.基质金属蛋白酶与扁平苔藓[J].山西医科大学学报,2006,37(4):440-442. 被引量:3
  • 4王岩,陈卫民,孙国洪.口腔鳞癌中VEGF和MMP-2的表达及其相关性[J].临床口腔医学杂志,2006,22(12):707-709. 被引量:4
  • 5Tortorici S, Mauro A, Burmano F, et al. Matrix metallo- proteinase- 2 matrix metalloproteinase- 9 and inducible nitric oxide synthase in oral leukoplakia: immunohisto- chemistry and RT - PCR analysis [ J ]. Laryngoscope, 2008, 118(8) : 1395 - 1399.
  • 6Tortorici S, Mauro A, Burruano F, et al. Matrix metallo- proteinase- 2 matrix metalloproteinase -9 and inducible nitric oxide synthase in oral leukoplakia: immunohisto- chemistry and RT - PCR analysis [ J ]. J Biol Regul Ho- meost Agents, 2008,22 (2) : 125 - 130.
  • 7Mazzarella N, Femiano F, Gombos F, et al. Matrix metallo- proteinasegene expression in oral lichen planus:erosive vs. reticular forms [ J ]. J Eur Acad Delanatol Venereol,2006,20 (8) :953 -957.
  • 8Rubaci AH, Kazancioglu HO,Olgac V, et al. The roles of matrix metalloproteinases - 2, - 7, - 10 and tissue inhibi- tor of metalloproteinase - 1 in the pathogenesis of oral li- chen planus[Jl. J Oral Pathol Med, 2012,41(9):689 - 696.
  • 9Paulusova V, Laco J, Drizhal I, et al. Expression of ma- trix metalloproteinase 9 in patients with oral lichen planus [ J ]. Acta Medica ( HradecKralove), 2012,55 ( 1 ) : 23 - 26.
  • 10Chen Y,Zhang W,Geng N,et al. MMPs, TIMP -2, and TGF - betal in the cancerization of oral lichen planus [ J ]. J Head Neck, 2008,30(9) :1237 -1245.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部